Glucose AUC
Biomarker2 papers2 findings
- Human trial2
Interventions
1Tirzepatide
downin humans1Moderate certainty
1 study
Tirzepatide
downin humans1Moderate certainty
Tirzepatide decreases glucose AUC in humans.
Human trialobesity disease without diabetesweek 72n = 225
Changes in Abdominal Adiposity and Associations With Metabolic Health Markers Following Tirzepatide in Japanese Participants With Obesity Disease: Results From the SURMOUNT-J Study · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 19 Sep 2026
Associations
1CNTF
downin humans1
1 study
CNTF
downin humans1
CNTF is associated with glucose AUC in humans.
Human trialvastus lateralisn = 67
Ciliary Neurotrophic Factor in Skeletal Muscle of Older Adults and the Effects of Weight Loss and Aerobic Training · Metabolites · 21 Aug 2026
Latest
5Diabetes, Obesity & MetabolismHumans
Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications
Diabetes, Metabolic Syndrome and ObesityReview
Acute Effects of Exercise Snacks on Glucose and Lipid Metabolic Outcomes in Individuals with Metabolic Disorders: A Systematic Review and Meta-Analysis
AAIC 2025 AbstractAnimals
Age, glucose tolerance, and cognitive performance in vervet monkeys
ADA Scientific Sessions 2025 AbstractHuman trial
Semaglutide Effect during Mixed-Meal Tolerance Test (MMTT) with Fully Closed-Loop Therapy in Type 1 Diabetes (T1D)
ADA Scientific Sessions 2025 AbstractHuman trial
Effects of a 6-Month Lifestyle Intervention for Type 2 Diabetes Featuring Intermittent Energy Restriction or Time-Restricted Eating on Glucose Tolerance and Body Weight
ADA Scientific Sessions 2025 AbstractHuman trial
Effect of Anthocyanin Supplementation on β-cell Function and Insulin Sensitivity in Subjects With Impaired Glucose Tolerance—Role of Skin AGEs
ADA Scientific Sessions 2025 AbstractHuman trial